Methods to improve the detection of mild cognitive impairment.

We examined whether the performance of the National Institute of Aging's Consortium to Establish a Registry for Alzheimer's Disease's 10-word list (CWL), part of the consortium's neuropsychological battery, can be improved for detecting Alzheimer's disease and related disorders early. We focused on mild cognitive impairment (MCI) and mild dementia because these stages often go undetected, and their detection is important for treatment. Using standardized diagnostic criteria combined with history, physical examination, and cognitive, laboratory, and neuroimaging studies, we staged 471 community-dwelling subjects for dementia severity by using the Clinical Dementia Rating Scale. We then used correspondence analysis (CA) to derive a weighted score for each subject from their item responses over the three immediate- and one delayed-recall trials of the CWL. These CA-weighted scores were used with logistic regression to predict each subject's probability of impairment, and receiver operating characteristic analysis was used to measure accuracy. For MCI vs. normal, accuracy was 97% [confidence interval (C.I.) 97-98%], sensitivity was 94% (C.I. 93-95%), and specificity was 89% (C.I. 88-91%). For MCI/mild dementia vs. normal, accuracy was 98% (C.I. 98-99%), sensitivity was 96% (C.I. 95-97%), and specificity was 91% (C.I. 89-93%). MCI sensitivity was 12% higher (without lowering specificity) than that obtained with the delayed-recall total score (the standard method for CWL interpretation). Optimal positive and negative predictive values were 100% and at least 96.6%. These results show that CA-weighted scores can significantly improve early detection of Alzheimer's disease and related disorders.

[1]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[2]  D. M. Green,et al.  Signal detection theory and psychophysics , 1966 .

[3]  Maurice G. Kendall,et al.  The advanced theory of statistics , 1945 .

[4]  B. Gordon,et al.  Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. , 2001, Archives of neurology.

[5]  Minh Quach,et al.  Screening for mild cognitive impairment (MCI) utilizing combined mini‐mental‐cognitive capacity examinations for identifying dementia prodromes , 2002, International journal of geriatric psychiatry.

[6]  A. Iguchi,et al.  The Clock Drawing Test as a Valid Screening Method for Mild Cognitive Impairment , 2004, Dementia and Geriatric Cognitive Disorders.

[7]  D. Rubin,et al.  Statistical Analysis with Missing Data. , 1989 .

[8]  J. Cummings,et al.  Evaluating dementia screening tests , 1999, Neurology.

[9]  W. Batchelder,et al.  A multinomial modeling analysis of memory deficits in Alzheimer's disease and vascular dementia. , 1997, The journals of gerontology. Series B, Psychological sciences and social sciences.

[10]  Alan D. Baddeley,et al.  Analysis of the episodic memory deficit in early Alzheimer's disease: Evidence from the doors and people test , 1996, Neuropsychologia.

[11]  R. Mohs,et al.  Reliability and validity of a chronic care facility adaptation of the Clinical Dementia Rating scale , 2001, International journal of geriatric psychiatry.

[12]  The validity and reliability of a Computerized Dementia Screening Test developed in Korea , 2002, Journal of the Neurological Sciences.

[13]  Ranjan Duara,et al.  Semantic interference deficits and the detection of mild Alzheimer's disease and mild cognitive impairment without dementia , 2004, Journal of the International Neuropsychological Society.

[14]  J. Cummings Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[15]  Steven Potkin,et al.  Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial. , 2003, Archives of neurology.

[16]  W M Tierney,et al.  Documentation and Evaluation of Cognitive Impairment in Elderly Primary Care Patients , 1995, Annals of Internal Medicine.

[17]  F. Craik,et al.  The Oxford handbook of memory , 2006 .

[18]  R. Larumbe [Detection of early cases of Alzheimer's disease. Application of the CERAD neuropsychological test battery]. , 1997, Revista de medicina de la Universidad de Navarra.

[19]  D. Geldmacher,et al.  Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.

[20]  J. Duchek,et al.  Reliability of clinical nurse specialists in the staging of dementia. , 1989, Archives of neurology.

[21]  A M Clarfield,et al.  The reversible dementias: do they reverse? , 1988, Annals of internal medicine.

[22]  J. Kessler,et al.  DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia , 2004, International journal of geriatric psychiatry.

[23]  M. Farlow,et al.  A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease , 2000, European Neurology.

[24]  A. Desai,et al.  Review of rivastigmine and its clinical applications in Alzheimer’s disease and related disorders , 2001, Expert opinion on pharmacotherapy.

[25]  N. Lavrac,et al.  Intelligent Data Analysis in Medicine and Pharmacology , 1997 .

[26]  A. M. Clarfield,et al.  The decreasing prevalence of reversible dementias: an updated meta-analysis. , 2003, Archives of internal medicine.

[27]  D. Loewenstein,et al.  Utility of a modified mini‐mental state examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders , 2000, International journal of geriatric psychiatry.